Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety, tolerability and blood concentration of
AZD3839 following oral administration of single doses in healthy men and women of
non-childbearing potential